Rankings
▼
Calendar
VMD (Viemed Healthcare, Inc.) Stock Financials & Earnings | Market Cap Arena
VMD
Viemed Healthcare, Inc.
Mkt Cap
$373M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$270M
Net Income (TTM)
$15M
EPS (TTM)
$0.37
Free Cash Flow (TTM)
$12M
Gross Margin
57.5%
Op. Margin
8.5%
Net Margin
5.5%
FCF Margin
4.4%
P/S Ratio (TTM)
1.4x
P/E Ratio (TTM)
25.0x
YoY Rev Growth
+20.5%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$40M
$24M
$2M
Q2 23
$43M
$26M
$3M
Q3 23
$49M
$31M
$4M
Q4 23
$51M
$32M
$5M
Q1 24
$51M
$30M
$2M
Q2 24
$55M
$33M
$4M
Q3 24
$58M
$34M
$6M
Q4 24
$61M
$36M
$6M
Q1 25
$59M
$33M
$4M
Q2 25
$63M
$36M
$5M
Q3 25
$72M
$41M
$6M
Q4 25
$76M
$44M
$9M
marketcaparena.com
Revenue Breakdown
VMD
Viemed Healthcare, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
2.6x
62.4x
Q2 23
2.4x
50.8x
Q3 23
2.2x
40.5x
Q4 23
2.0x
36.4x
Q1 24
1.9x
36.1x
Q2 24
1.8x
39.4x
Q3 24
1.7x
35.8x
Q4 24
1.7x
33.1x
Q1 25
1.6x
30.3x
Q2 25
1.5x
26.7x
Q3 25
1.5x
27.4x
Q4 25
1.4x
25.0x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$10M
$6M
Q2 23
$8M
$2M
Q3 23
$14M
$6M
Q4 23
$13M
$5M
Q1 24
$1M
-$5M
Q2 24
$10M
$1M
Q3 24
$13M
$2M
Q4 24
$15M
$3M
Q1 25
$3M
-$13M
Q2 25
$12M
$4M
Q3 25
$18M
$11M
Q4 25
$18M
$10M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$5M
Q2 23
$6M
Q3 23
$7M
Q4 23
$8M
Q1 24
$6M
Q2 24
$9M
Q3 24
$11M
Q4 24
$12M
Q1 25
$15M
Q2 25
$8M
Q3 25
$8M
Q4 25
$9M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+22.6%
+25.4%
Q2 23
+30.0%
+25.1%
Q3 23
+38.2%
+31.8%
Q4 23
+35.3%
+33.8%
Q1 24
+27.9%
+28.6%
Q2 24
+26.9%
+27.1%
Q3 24
+17.4%
+15.9%
Q4 24
+19.6%
+19.3%
Q1 25
+16.9%
+14.3%
Q2 25
+14.7%
+14.0%
Q3 25
+24.0%
+26.5%
Q4 25
+25.5%
+23.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$1M
3.5%
Q2 23
$1M
3.4%
Q3 23
$1M
2.9%
Q4 23
$2M
3.0%
Q1 24
$1M
2.8%
Q2 24
$2M
2.9%
Q3 24
$2M
3.0%
Q4 24
$2M
2.5%
Q1 25
$2M
3.9%
Q2 25
$2M
3.7%
Q3 25
$2M
3.0%
Q4 25
$2M
3.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$780K
$21M
—
Q2 23
$758K
$22M
—
Q3 23
$593K
$25M
—
Q4 23
$651K
$25M
—
Q1 24
$750K
$26M
—
Q2 24
$758K
$28M
—
Q3 24
$757K
$28M
—
Q4 24
$803K
$30M
—
Q1 25
$797K
$31M
—
Q2 25
$847K
$31M
—
Q3 25
$775K
—
$33M
Q4 25
$598K
—
$32M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$24M
$0
$24M
Q2 23
$10M
$0
$10M
Q3 23
$10M
$0
$10M
Q4 23
$13M
$0
$13M
Q1 24
$7M
$0
$7M
Q2 24
$9M
$0
$9M
Q3 24
$11M
$0
$11M
Q4 24
$18M
$0
$18M
Q1 25
$10M
$0
$10M
Q2 25
$20M
$0
$20M
Q3 25
$11M
$0
$11M
Q4 25
$14M
$0
$14M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
40M
+1.3%
Q2 23
41M
+1.6%
Q3 23
40M
-0.6%
Q4 23
40M
-0.1%
Q1 24
41M
+0.5%
Q2 24
41M
-0.1%
Q3 24
41M
+0.6%
Q4 24
42M
+1.8%
Q1 25
42M
+0.3%
Q2 25
41M
-1.3%
Q3 25
40M
-1.4%
Q4 25
40M
-0.8%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
—
—
FY 19
$192K
418
FY 20
$257K
511
FY 21
$187K
627
FY 22
$187K
743
FY 23
$184K
996
FY 24
$190K
1K
FY 25
$196K
1K
marketcaparena.com